Role of methionine adenosyltransferase genes in hepatocarcinogenesis

Cancers

Volumn 3, Issue 2, 2011, Pages 1480-1497

  Ramani, Komal ^a   Moto, José M ^b   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Hepatocellular carcinoma (HCC); Methionine adenosyltransferase (MAT); S adenosylmethionine (adoMet)

Indexed keywords

MESSENGER RNA; METHIONINE ADENOSYLTRANSFERASE; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; CANCER PREVENTION; CELL INFILTRATION; CELL PROLIFERATION; CONTINUOUS INFUSION; DNA METHYLATION; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME SYNTHESIS; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METABOLISM; MAT1A GENE; MAT2A GENE; MAT2B GENE; METHIONINE ADENOSYLTRANSFERASE GENE; NONHUMAN; PROTEIN RNA BINDING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79959806624     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3021480     Document Type: Review

References (73)

1. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94, 153-156.
2. El-Serag, H.B.; Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. New Eng. J. Med. 1999, 340, 745-750.
3. Feitelson, M.A.; Sun, B.; Satiroglu Tufan, N.L.; Liu, J.; Pan, J.; Lian, Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002, 21, 2593-2604.
4. Bosch, F.X.; Ribes, J.; Diaz, M.; Cleries, R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127, S5-S16.
5. Woo, H.G.; Wang, X.W.; Budhu, A.; Kim, Y.H.; Kwon, S.M.; Tang, Z.Y.; Sun, Z.; Harris, C.C.; Thorgeirsson, S.S. Association of TP53 Mutations with Stem Cell-Like Gene Expression and Survival of Patients with Hepatocellular Carcinoma. Gastroenterology 2010, doi:10.1053/j.gastro.2010.11.034.
6. Glauert, H.P.; Calfee-Mason, K.; Stemm, D.N.; Tharappel, J.C.; Spear, B.T. Dietary antioxidants in the prevention of hepatocarcinogenesis: A review. Mol. Nutr. Food Res. 2010, 54, 875-896.
7. Zhuravleva, E.; Tschopp, O.; Hemmings, B.A. Role of PKB/AKT in Liver diseases. In Signaling Pathways in Liver Diseases, 2nd ed.; Dufour, J.-F., Clavien, P.-A., Eds.; Springer-Verlag: Berlin, Heidelberg, German, 2010; Volume 578, pp. 243-259.
8. Schwabe, R. JNKs in liver diseases. In Signaling Pathways in Liver Diseases, 2nd ed.; Dufour, J.-F., Clavien, P.-A., Eds.; Springer-Verlag: Berlin, Heidelberg, German, 2010; Volume 578, pp. 215-226.
9. Mato, J.M.; Corrales, F.J.; Lu, S.C.; Avila, M.A. S-Adenosylmethionine: A control switch that regulates liver function. FASEB J. 2002, 16, 15-26.
10. Finkelstein, J.D. Methionine metabolism in mammals. J. Nutr. Biochem. 1990, 1, 228-237.
11. Lu, S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. Faseb J. 1999, 13, 1169-1183.
12. Finkelstein, J.D. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin. Chem. Lab. Med. 2007, 45, 1694-1699.
13. Clarke, S.G. Inhibition of mammalian protein methyltransferases by 5'-methylthioadenosine (MTA): A mechanism of action of dietary SAMe? Enzymes 2006, 24, 467-493.
14. Kotb, M.; Mudd, S.H.; Mato, J.M.; Geller, A.M.; Kredich, N.M.; Chou, J.Y.; Cantoni, G.L. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 1997, 13, 51-52.
15. Halim, A.B.; LeGros, L.; Geller, A.; Kotb, M. Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells. J. Biol. Chem. 1999, 274, 29720-29725.
16. Gil, B.; Casado, M.; Pajares, M.A.; Bosca, L.; Mato, J.M.; Martin-Sanz, P.; Alvarez, L. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. Hepatology 1996, 24, 876-881.
17. Reytor, E.; Perez-Miguelsanz, J.; Alvarez, L.; Perez-Sala, D.; Pajares, M.A. Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution. Faseb J. 2009, 23, 3347-3360.
18. Lu, S.C.; Gukovsky, I.; Lugea, A.; Reyes, C.N.; Huang, Z.Z.; Chen, L.; Mato, J.M.; Bottiglieri, T.; Pandol, S.J. Role of S-adenosylmethionine in two experimental models of pancreatitis. FASEB J. 2003, 56-58.
19. Horikawa, S.; Tsukada, K. Molecular cloning and developmental expression of a human kidney S-adenosylmethionine synthetase. FEBS Lett. 1992, 312, 37-41.
20. Okada, G.; Teraoka, H.; Tsukada, K. Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. Biochemistry 1981, 20, 934-940.
21. Pajares, M.A.; Duran, C.; Corrales, F.; Pliego, M.M.; Mato, J.M. Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J. Biol. Chem. 1992, 267, 17598-17605.
22. Sullivan, D.M.; Hoffman, J.L. Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isozymes. Biochemistry 1983, 22, 1636-1641.
23. Cai, J.; Mao, Z.; Hwang, J.J.; Lu, S.C. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepato cellular carcinoma cells. Cancer Res. 1998, 58, 1444-1450.
24. Martinez-Chantar, M.L.; Garcia-Trevijano, E.R.; Latasa, M.U.; Martin-Duce, A.; Fortes, P.; Caballeria, J.; Avila, M.A.; Mato, J.M. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology 2003, 124, 940-948.
25. Torres, L.; Avila, M.A.; Carretero, M.V.; Latasa, M.U.; Caballerîa, J.; López-Rodas, G.; Boukaba, A.; Lu, S.C.; Franco, L.; Mato, J.M. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. Faseb J. 2000, 14, 95-102
26. Avila, M.A.; Berasain, C.; Torres, L.; Martin-Duce, A.; Corrales, F.J.; Yang, H.P.; Prieto, J.; Lu, S.C.; Caballeria, J.; Rodes, J.; Mato, J.M. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 2000, 33, 907-914.
27. Vásquez, M.; Fernández, D.; Embade, N.; Woodhoo, A.; Martinez, N.; Varela-Rey, M.; Luka, Z.; Wagner, C.; Caballería, J.; Gorospe, M.; Lu, S.C.; Mato, J.M.; Martínez-Chantar, M.L. HuR/Methylated-HuR and AUF1 regulate the expression of methionine adenosyltransferase during liver proliferation, differentiation and carcinogenesis. Gastroenterology 2010, 138, 1943-1953.
28. Zhang, W.; Wagner B.J.; Ehrenman, K.; Schaefer, A.W.; De Maria, C.T.; Crater, D.; DeHaven, K.; Long, L.; Brewer, G. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 1993, 13, 7652-7665.
29. Yang, H.; Huang, Z.; Wang, J.; Lu, S.C. The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. FASEB J. 2001, 15, 1507-1516.
30. Yang, H.P.; Sadda, M.R.; Yu, V.; Zeng, Y.; Lee, T.D.; Ou, X.P.; Chen, L.X.; Lu, S.C.; Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha: Role of NF-κB and AP-1. J. Biol. Chem. 2003, 278, 50887-50896.
31. Yang, H.P.; Huang, Z.Z.; Zeng, Z.H.; Chen, C.J.; Selby, R.R.; Lu, S.C. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am. J. Physiol. 2001, 280, G184-G190.
32. Latasa, M.U.; Boukaba, A.; Garcia-Trevijano, E.R.; Torres, L.; Rodriguez, J.L.; Caballeria, J.; Lu, S.C.; Lopez-Rodas, G.; Franco, L.; Mato, J.M.; Avila, M.A. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration. FASEB J. 2001, 15, 1248-1250.
33. Lu, S.C.; Mato, J.M. S-adenosylmethionine in cell growth, apoptosis and liver cancer. J. Gastroenterol. Hepatol. 2008, 1, S73-S77.
34. Yang, H.P.; Iglesias Ara, A.; Magilnick, N.; Xia, M.; Ramani, K.; Chen, H.; Lee, T.D.; Mato, J.M.; Lu, S.C. Expression pattern, regulation and function of methionine adenosyltransferase 2β alternative splicing variants in hepatoma cells. Gastroenterology 2008, 134, 281-291.
35. Ramani, K.; Yang, H.P.; Xia, M.; Iglesias Ara, A.; Mato, J.M.; Lu, S.C. Leptins mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β. Hepatology 2008, 47, 521-531.
36. Martinez-Chantar, M.L.; Corrales, F.J.; Martinez-Cruz, L.A.; Garcia-Trevijano, E.R.; Huang, Z.Z.; Chen, L.; Kanel, G.; Avila, M.A.; Mato, J.M.; Lu, S.C. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. Faseb J. 2002, 16, 1292-1294.
37. Cai, J.; Sun, W.M.; Hwang, J.J.; Stain, S.C.; Lu, S.C. Changes in S-adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance. Hepatology 1996, 24, 1090-1097.
38. Martinez-Chantar, M.L.; Garcia-Trevijano, E.R Latasa, M.U,Perez-Mato, I, Sanchez del Pino, M.M.; Corrales, F.J.; Avila, M.A.; Mato, J.M. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am. J. Clin. Nutr. 2002, 76, 1177S-1182S.
39. Lu, S.C.; Alvarez, L.; Huang, Z.Z.; Chen, L.; An, W.; Corrales, F.J.; Avila, M.A.; Kanel, G.; Mato, J.M. Methionine adenosyl transferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. USA 2001, 98, 5560-5565.
40. Dumble, M.L.; Croager, E.J.; Yeoh, G.C.; Quail, E.A. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepato cellular carcinoma. Carcinogenesis 2002, 23, 435-445.
41. Jelnes, P.; Santoni-Rugiu, E.; Rasmussen, M.; Friis, S.L.; Nielsen, J.H.; Tygstrup, N.; Bisgaard, H.C. Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology 2007, 45, 1462-1470.
42. Rountree, C.B.; Senadheera, S.; Mato, J.M.; Crooks, G.M.; Lu, S.C. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology 2008, 47, 1288-1297.
43. Ding, W.; Mouzaki, M.; You, H.; Laird, J.C.; Mato, J.; Lu, S.C.; Rountree, C.B. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology 2009, 49, 1277-1286
44. Ding, W.; Mouzaki, M.; You, H.; Laird, J.C.; Mato, J.; Lu, S.C.; Rountree, C.B. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology 2009, 49, 1277-1286.
45. Huynh, H.; Nguyen, T.T.; Chow, K.H.; Tan, P.H.; Soo, K.C.; Tran, E. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterology 2003, 3, 19.
46. Nguyen, L.N.; Furuya, M.H.; Wolfraim, L.A.; Nguyen, A.P.; Holdren, M.S.; Campbell, J.S.; Knight, B.; Yeoh, G.C.; Fausto, N.; Parks, W.T. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007, 45, 31-41.
47. Eden, A.; Gaudet, F.; Waghmare, A.; Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300, 455.
48. Calvisi, D.F.; Simile, M.M.; Ladu, S.; Pellegrino, R.; De Murtas, V.; Pinna, F.; Tomasi, M.L.; Frau, M.; Virdis, P.; De Miglio, M.R.; Muroni, M.R.; Pascale, R.M.; Feo, F. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int. J. Cancer 2007, 121, 2410-2420.
49. Mann, C.D.; Neal, C.P.; Garcea, G.; Manson, M.M.; Dennison, A.R.; Berry, D.P. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur. J. Cancer 2007, 43, 979-992.
50. Mol, C.D.; Hosfield, D.J.; Tainer, J.A. Abasic site recognition by two apurinic/apyrimidinic endonuclease families in DNA base excision repair: the 3' ends justify the means. Mutat. Res. 2000, 460, 211-229.
51. Ramana, C.V.; Boldogh, I.; Izumi, T.; Mitra, S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc. Natl. Acad. Sci USA 1998, 95, 5061-5066.
52. Grosch, S.; Fritz, G.; Kaina, B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res. 1998, 58, 4410-4416.
53. Tomasi, M.L.; Iglesias-Ara, A.; Yang, H.; Ramani, K.; Feo, F.; Pascale, M.R.; Martinez-Chantar, M.L.; Mato, J.M.; Lu, S.C. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis. Gastroenterology 2009, 136, 1025-1036.
54. Tonks, N.K.; Neel, B.G. From form to function: Signaling by protein tyrosine phosphatases. Cell 1996, 87, 365-368.
55. Lin, Y.W.; Chuang, S.M.; Yang, J.L. ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J. Biol. Chem. 2003, 278, 21534-21541.
56. Calvisi, D.F.; Pinna, F.; Meloni, F.; Ladu, S.; Pellegrino, R.; Sini, M.; Daino, L.; Simile, M.M.; De Miglio, M.R.; Virdis, P.; Frau, M.; Tomasi, M.L.; Seddaiu, M.A.; Muroni, M.R.; Feo, F.; Pascale, R.M. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res. 2008, 68, 4192-4200.
57. Tomasi, M.L.; Ramani, K.; Lopitz-Otsoa, F.; Rodriguez, M.S.; Li, T.W.; Ko, K.; Yang, H.; Bardag-Gorce, F.; Iglesias-Ara, A.; Feo, F.; Pascale, M.R.; Mato, J.M.; Lu, S.C. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. Hepatology 2010, 51, 2152-2161.
58. Martínez-Chantar, M.L.; Vázquez-Chantada, M.; Garnacho-Echevarria, M.; Latasa, M.U.; Varela-Rey, M.; Dotor, J.; Santamaria, M.; Martínez-Cruz, L.A.; Parada, L.A.; Lu, S.C.; Mato, J.M. S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology 2006, 131, 223-232.
59. Vázquez-Chantada, M.; Ariz, U.; Varela-Rey, M.; Embade, N.; Martínez-Lopez, N; Fernández-Ramos, D., Gómez-Santos, L, Lamas, S, Lu, S.C., Martínez-Chantar, M.L, Mato, J.M. Evidence for an LKB1/AMPK/eNOS Cascade Regulated by HGF, S-Adenosylmethionine and NO in Hepatocyte Proliferation. Hepatology 2009, 49, 608-617.
60. Martínez-López, N.; Varela-Rey, M.; Fernández-Ramos, D,; Woodhoo, A.; Vázquez-Chantada, M.; Embade, N.; Espinosa-Hevia, L.; Bustamante, F.J.; Parada, L.A.; Rodriguez, M.S.; Lu, S.C.; Mato, J.M.; Martínez-Chantar, M.L. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology 2010, 52, 1621-1631.
61. Paneda, C.; Gorospe, I.; Herrera, B.; Nakamura, T.; Fabregat, I.; Varela-Nieto, I. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology 2002, 35, 1381-1391.
62. Saxena, N.K.; Sharma, D.; Ding, X.; Lin, S.; Marra, F.; Merlin, D.; Anania, F.A. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007, 67, 2497-2507.
63. Schwabe, R.F.; Brenner, D.A. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G583-G589.
64. Xia, M.; Chen, Y.; Wang, L.C.; Zandi, E.; Yang, H.; Bemanian, S.; Martinez-Chantar, M.L.; Mato, J.M.; Lu, S.C. Novel function and intracellular localization of methionine adenosyltransferase 2beta splicing variants. J. Biol. Chem. 2010, 285, 20015-20021.
65. Vazquez-Chantada, M.; Fernandez-Ramos, D.; Embade, N.; Martinez-Lopez, N.; Varela-Rey, M.; Woodhoo, A.; Luka, Z.; Wagner, C.; Anglim, P.P.; Finnell, R.H.; Caballeria, J.; Laird-Offringa, I.A.; Gorospe, M.; Lu, S.C.; Mato, J.M.; Martinez-Chantar, M.L. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology 2010, 138, 1943-1953.
66. Garcea, R.; Daino, L.; Pascale, R.; Simile, M.M.; Puddu, M.; Ruggiu, M.E.; Seddaiu, M.A.; Satta, G.; Sequenza, M.J.; Feo, F. Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. Carcinogenesis 1989, 10, 1183-1192.
67. Pascale, R.M.; Marras, V.; Simile, M.M.; Daino, L.; Pinna, G.; Bennati, S.; Carta, M.; Seddaiu, M.A.; Massarelli, G.; Feo, F. Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. Cancer Res. 1992, 52, 4979-4986.
68. Lu, S.C.; Ramani, K.; Ou, X.; Lin, M.; Yu, V.; Ko, K.; Park, R.; Bottiglieri, T.; Tsukamoto, H.; Kanel, G.; French, S.W.; Mato, J.M.; Moats, R.; Grant, E. S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology 2009, 50, 462-471.
69. Li, J.; Ramani, K.; Sun, Z.; Zee, C.; Grant, E.G.; Yang, H.; Xia, M.; Oh, P.; Ko, K.; Mato, J.M.; Lu, S.C. Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am. J. Pathol. 2010, 176, 2456-2466.
70. Zhao, J.; Dong, L.; Lu, B.; Wu, G.; Xu, D.; Chen, J.; Li, K.; Tong, X.; Dai, J.; Yao, S.; Wu, M.; Guo, Y. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 2008, 135, 956-968.
71. Millward, T.A.; Zolnierowicz, S.; Hemmings, B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 1999, 24, 186-191.
72. Martinez-Chantar, M.;, Vázquez-Chantada, M.; Ariz, U.; Martínez, N.; Varela, M.; Luka, Z.; Capevila, A.; Rodriguez, J.; Aransay, A.M.; Matthiesen, R.; Yang, H.P.; Calvisi, D.F.; Esteller, M.; Fraga, M.; Lu, S.C.; Wagner, C.; Mato, J.M. Loss of the GNMT gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008, 47, 1191-1199.
73. Calvisi, D.F.; Ladu, S.; Gorden, A.; Farina, M.; Conner, E.A.; Lee, J.S.; Factor, V.M.; Thorgeirsson, S.S. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006, 130, 1117-1128.